id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0447-0111,FDA,FDA-2012-N-0447,"Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals",Notice,Notice of Approval,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,,2016-07-11T13:36:13Z,2016-16349,0,0,090000648209c0b3
FDA-2012-N-0447-0109,FDA,FDA-2012-N-0447,Congresswoman Slaughter's Letter to FDA,Supporting & Related Material,Background Material,2016-05-11T04:00:00Z,2016,5,,,2016-05-26T15:41:08Z,,0,0,0900006481fc3b77
FDA-2012-N-0447-0108,FDA,FDA-2012-N-0447,Antimicrobial Animal Drug Sales and Distribution Reporting,Rule,Final Rule,2016-05-11T04:00:00Z,2016,5,2016-05-11T04:00:00Z,,2016-05-11T14:45:33Z,2016-11082,0,0,0900006481fc35b3
FDA-2012-N-0447-0110,FDA,FDA-2012-N-0447,Antimicrobial Animal Drug Sales and Distribution Reporting Final Regulatory Impact Analysis,Supporting & Related Material,Background Material,2016-05-11T04:00:00Z,2016,5,,,2016-05-11T14:59:40Z,,0,0,0900006481fc3bca